Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 015486/0573 | |
| Pages: | 12 |
| | Recorded: | 06/21/2004 | | |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE 1ST ASSIGNOR'S NAME. DOCUMENT PREVIOUSLY RECORDED ON REEL 014681 FRAME 0988. ASSIGNOR HEREBY CONFIRM THE ASSIGNMENT OF THE ENTIRE INTEREST. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10603406
|
Filing Dt:
|
06/24/2003
|
|
Publication #:
|
|
Pub Dt:
|
04/08/2004
| | | | |
|
Title:
|
Enhancing treatment of MDR cancer with adenosine A3 antagonists
|
|
|
Assignee
|
|
|
|
|
| CENTREGREEN TWO, SUITE 300 |
| 4000 CENTREGREEN WAY |
| CARY, NORTH CAROLINA 27513 |
|
|
Correspondence name and address
|
| |
EDWARDS & ANGELL, LLP
|
| |
DAVID G. CONLIN, ESQ.
|
| |
P.O. BOX 9169
|
| |
BOSTON, MA 02209
|
Search Results as of:
05/30/2024 12:15 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
